Ishiwa, Sho
Kamei, Koichi http://orcid.org/0000-0003-3528-6961
Tanase-Nakao, Kanako
Shibata, Shinsuke
Matsunami, Kunihiro
Takeuchi, Ichiro
Sato, Mai
Ishikura, Kenji
Narumi, Satoshi
Article History
Received: 9 June 2020
Accepted: 5 August 2020
First Online: 12 August 2020
Ethics approval and consent to participate
: Ethics approval was not applicable. Consent for publication was obtained from her family.
: Written informed consent for publication was obtained from her family as participants were under 16 years old.
: Kamei received grants from the Terumo Foundation for Life Sciences and Arts, Chugai Pharmaceutical Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co., and Pfizer Japan, Inc., and lecture fees from Tanabe Mitsubishi Pharma, Novartis Pharma K.K., Chugai Pharmaceutical Co. Ltd. and AbbVie Inc. Ishikura received grants from Asahi Kasei Pharma, Chugai Pharmaceutical Co., Ltd., Novartis Pharma, and Zenyaku Kogyo Co. Ltd. and lecture fees from Asahi Kasei Pharma, Chugai Pharmaceutical Co., Ltd., Zenyaku Kogyo Co., Ltd., and Novartis Pharma K.K.